🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 22 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 22/03/2006 | 49,03 | 50,42 | 49,03 | 50,34 | +2,67% | 2,82% | 160.407 |
| 21/03/2006 | 49,03 | 49,97 | 48,47 | 49,03 | +0,38% | 3,05% | 225.569 |
| 20/03/2006 | 49,78 | 49,93 | 48,10 | 48,85 | -0,76% | 3,68% | 148.224 |
| 17/03/2006 | 48,66 | 50,72 | 46,79 | 49,22 | +1,15% | 8,08% | 423.940 |
| 16/03/2006 | 45,36 | 48,85 | 45,29 | 48,66 | +7,00% | 7,84% | 381.541 |
| 15/03/2006 | 44,17 | 46,04 | 42,78 | 45,48 | +2,97% | 7,37% | 324.420 |
| 14/03/2006 | 44,24 | 44,54 | 43,72 | 44,17 | -0,42% | 1,86% | 216.111 |
| 13/03/2006 | 44,17 | 44,92 | 44,17 | 44,35 | -0,42% | 1,69% | 38.071 |
| 10/03/2006 | 44,17 | 44,92 | 44,17 | 44,54 | +0,85% | 1,69% | 53.861 |
| 09/03/2006 | 44,17 | 44,92 | 44,17 | 44,17 | +0,00% | 1,69% | 79.829 |
| 08/03/2006 | 46,53 | 46,79 | 44,05 | 44,17 | -5,52% | 5,87% | 192.333 |
| 07/03/2006 | 47,16 | 47,46 | 46,04 | 46,75 | -1,26% | 3,02% | 34.732 |
| 06/03/2006 | 46,60 | 47,54 | 46,41 | 47,35 | +0,40% | 2,41% | 40.983 |
| 03/03/2006 | 46,97 | 47,16 | 46,41 | 47,16 | -0,40% | 1,59% | 25.728 |
| 02/03/2006 | 46,79 | 47,35 | 46,56 | 47,35 | +0,48% | 1,68% | 123.084 |
| 01/03/2006 | 46,45 | 48,21 | 46,04 | 47,12 | +1,12% | 4,67% | 100.936 |
| 28/02/2006 | 46,15 | 46,60 | 45,33 | 46,60 | +0,97% | 2,76% | 67.059 |
| 27/02/2006 | 45,85 | 46,41 | 45,10 | 46,15 | +0,24% | 2,86% | 40.048 |
| 24/02/2006 | 46,60 | 47,16 | 45,59 | 46,04 | -2,77% | 3,37% | 25.301 |
| 23/02/2006 | 45,85 | 47,35 | 44,77 | 47,35 | +2,85% | 5,63% | 149.961 |
| 22/02/2006 | 48,10 | 48,17 | 45,85 | 46,04 | -5,02% | 4,83% | 116.244 |
| 21/02/2006 | 48,62 | 48,77 | 47,54 | 48,47 | -0,38% | 2,54% | 42.533 |
| 17/02/2006 | 48,40 | 48,85 | 48,02 | 48,66 | +0,39% | 1,70% | 88.325 |
| 16/02/2006 | 48,62 | 48,85 | 48,40 | 48,47 | -0,38% | 0,92% | 61.609 |
| 15/02/2006 | 48,77 | 48,81 | 48,40 | 48,66 | -0,38% | 0,84% | 40.289 |
| 14/02/2006 | 49,41 | 49,59 | 48,47 | 48,85 | -1,14% | 2,27% | 318.169 |
| 13/02/2006 | 48,43 | 51,28 | 48,13 | 49,41 | +2,33% | 6,49% | 263.560 |
| 10/02/2006 | 48,10 | 48,66 | 48,10 | 48,28 | +0,39% | 1,17% | 122.389 |
| 09/02/2006 | 47,91 | 48,66 | 47,16 | 48,10 | +0,23% | 3,13% | 265.403 |
| 08/02/2006 | 47,54 | 48,66 | 47,42 | 47,99 | +1,10% | 2,60% | 200.722 |